Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07019259 · ClinicalTrials.gov registry record · NA
Light Therapy for Chemotherapy Induced Peripheral Neuropathy in Childhood Cancer Survivors
A NA study of Cancer and Chemotherapy-induced Peripheral Neuropathy, sponsored by Yale University.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 2
- Study locations
NCT07019259 is a NA study of Cancer and Chemotherapy-induced Peripheral Neuropathy that is actively recruiting participants, run by Yale University. The registered enrollment target is 20 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT07019259, a NA study of Cancer and Chemotherapy-induced Peripheral Neuropathy, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to determine feasibility and acceptability of a six-week at-home light therapy protocol in childhood cancer survivors, to identify facilitators and barriers to implementing this intervention, and to measure signs and symptoms of Chemotherapy Induced Peripheral Neuropathy (CIPN) at baseline and following completion of the at-home light therapy protocol.
Conditions Studied
Interventions
- DEVICE Anodyne Therapy System
Study Locations (2)
Connecticut
- Yale New Haven Health Smilow York Street Hospital - New Haven
- Yale New Haven Health Park Avenue Medical Center - Trumbull
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-06-30 |
| Est. Completion | 2026-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07019259
The ClinicalTrials.gov registry entry for NCT07019259 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Anodyne Therapy System is the first listed.
NCT07019259 reports 2 study locations spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT07019259 about?
NCT07019259 is a clinical study titled "Light Therapy for Chemotherapy Induced Peripheral Neuropathy in Childhood Cancer Survivors". The purpose of this study is to determine feasibility and acceptability of a six-week at-home light therapy protocol in childhood cancer survivors, to identify facilitators and barriers to implementing this intervention, and to measure signs and symptoms of Chemotherapy Induced Peripheral Neuropathy...
What is the current status of trial NCT07019259?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-06-30. Estimated completion is 2026-09.
What conditions does trial NCT07019259 study?
This clinical trial studies the following conditions: Cancer, Chemotherapy-induced Peripheral Neuropathy, Childhood Cancer.
What interventions are being tested in trial NCT07019259?
The interventions under investigation include: Anodyne Therapy System (DEVICE).
Who is sponsoring clinical trial NCT07019259?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07019259 being conducted?
This trial has 2 study locations across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
BfedBwell Optimization Pilot
RECRUITING · NA
-
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
RECRUITING · NA
-
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
RECRUITING · NA
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.